Stock Fundamentals

INDV.US - Current Price

$32.75

Company Information

▼
Company Name
Indivior PLC Ordinary Shares
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: GB00BN4HT335
CIK: 0001625297
Currency: USD
Full Time Employees: 1,030
Phone: 804 379 1090
Website: https://www.indivior.com
Fiscal Year End: December
IPO Date: Dec 29, 2014
Description:

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Address:

10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235

Directors & Officers

▼
Name Title Year Born
Mr. Joseph J. Ciaffoni CEO & Director 1971
Mr. Ryan Preblick Chief Financial Officer 1976
Mr. Vishal Kalia Chief Strategy & Operating Officer 1981
Dr. Christian Heidbreder Chief Scientific Officer 1963
Mr. Jason Thompson Vice President of Investor Relations NA
Mr. Jeffrey W. Burris J.D. Chief Legal Officer 1972
Mr. Kevin L. Espinoza Chief Integrity & Compliance Officer NA
Ms. Angela Colon-Mahoney M.S. Chief Human Resources Officer 1976
Mr. Hillel West Chief Manufacturing & Supply Officer 1968
Mr. Patrick A. Barry Chief Commercial Officer 1968

Shares Statistics

▼
Shares Outstanding: 125.02M
Shares Float: 95.60M
% Insiders: 386.60%
% Institutions: 7,992.60%
Short % Float: 4.15%

Valuation Metrics

▼
Enterprise Value: $3.88B
Trailing P/E: 33.42
Forward P/E: 9.90

Financial Highlights

▼
Market Cap: $4.09B
EBITDA: $324.00M
P/E Ratio: $33.42
Book Value: $-1.66
Earnings/Share: $0.98
Profit Margin: 6.27%
Operating Margin: 36.94%
ROA (TTM): 13.15%
ROE (TTM): 12.20%
Revenue (TTM): $1.18B
Revenue/Share (TTM): $9.40
Earnings Growth (YOY): 106.30%
Revenue Growth (YOY): 2.30%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 0.42 N/A -10,000.00%
Sep 30, 2025 0.72 0.39 N/A 8,461.54%
Jun 30, 2025 0.51 0.24 N/A 11,250.00%
Mar 31, 2025 0.41 0.29 N/A 4,300.66%
Dec 31, 2024 0.32 0.26 N/A 2,265.38%
Sep 30, 2024 0.03 0.31 N/A -9,032.26%
Jun 30, 2024 -0.79 0.40 N/A -29,750.00%
Mar 31, 2024 0.37 0.42 N/A -1,190.48%
Dec 31, 2023 0.43 0.28 N/A 5,357.14%
Sep 30, 2023 -0.98 0.30 N/A -42,666.67%
Jun 30, 2023 0.39 0.22 N/A 7,727.27%
Mar 31, 2023 0.40 0.40 N/A 0.00%
Dec 31, 2022 -1.34 0.27 N/A -59,659.26%
Sep 30, 2022 0.28 0.29 N/A -344.83%
Jun 30, 2022 0.34 0.30 N/A 1,453.33%
Mar 31, 2022 0.28 0.30 N/A -826.67%
Dec 31, 2021 0.25 0.15 N/A 6,606.67%
Sep 30, 2021 0.15 0.15 N/A 0.00%
Jun 30, 2021 0.40 0.30 N/A 3,333.33%
Mar 31, 2021 0.51 0.25 N/A 10,476.00%
Dec 31, 2020 -0.09 0.15 N/A -15,906.67%
Sep 30, 2020 0.05 0.10 N/A -5,000.00%
Jun 30, 2020 0.10 0.10 N/A 0.00%
Mar 31, 2020 -1.11 -1.10 N/A -121.82%
Dec 31, 2019 -0.38 -0.25 N/A -5,052.00%
Sep 30, 2019 0.30 0.30 N/A 0.00%
Jun 30, 2019 0.50 0.50 N/A 0.00%
Mar 31, 2019 0.44 N/A N/A N/A
Dec 31, 2018 0.16 N/A N/A N/A
Sep 30, 2018 0.61 N/A N/A N/A
Jun 30, 2018 0.45 N/A N/A N/A
Mar 31, 2018 0.62 N/A N/A N/A
Dec 31, 2017 -1.00 N/A N/A N/A
Sep 30, 2017 0.35 N/A N/A N/A
Jun 30, 2017 0.51 N/A N/A N/A
Mar 31, 2017 0.53 N/A N/A N/A
Dec 31, 2016 0.50 N/A N/A N/A
Sep 30, 2016 -1.00 N/A N/A N/A
Jun 30, 2016 0.38 N/A N/A N/A
Mar 31, 2016 0.34 N/A N/A N/A
Dec 31, 2015 0.25 N/A N/A N/A
Sep 30, 2015 0.33 N/A N/A N/A
Jun 30, 2015 0.45 N/A N/A N/A
Mar 31, 2015 0.53 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $319.00M $N/A $1.32B $1.67B $-348.00M
2023-12-31 $316.00M $N/A $1.77B $1.96B $-191.00M
2022-12-31 $778.18M $N/A $1.78B $1.73B $51.28M
2021-12-31 $1.10B $N/A $1.83B $1.63B $203.00M
2020-12-31 $858.00M $N/A $1.53B $1.45B $82.00M
2019-12-31 $1.06B $N/A $1.65B $1.44B $209.00M
2018-12-31 $924.00M $N/A $1.55B $1.48B $66.00M
2017-12-31 $863.00M $N/A $1.44B $1.65B $-203.00M
2016-12-31 $692.00M $N/A $1.21B $1.50B $-295.00M

Watchlist

0

No stocks in watchlist